Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: May 2014

Rutgers Cancer Institute Leader Named Executive Officer of Big Ten Cancer Research Consortium

New Brunswick, NJ, May 30, 2014 Susan Goodin, Pharm.D., executive director of statewide affairs at Rutgers Cancer Institute of New Jersey has been appointed to serve as Executive Officer of the Big Ten Cancer Research Consortium (BTCRC).

The BTCRC, which fosters scientific collaboration between cancer centers at universities that are part of the Big Ten Conference, aims to develop unique nationwide clinical trial opportunities for patients.

In this role, Dr. Goodin will work closely with the consortium’s administration and member institutions to carry out this mission that has an initial focus of developing cutting-edge treatments for genitourinary, gastrointestinal, thoracic and breast cancers.  Continue reading

PhRMA CEO on Prescription Drug Costs: Can’t Focus on Cost and Ignore Value to Patient, Health Care System

Washington, DC, May 29, 2014 The Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani today released the following statement on the cost and value of medicines:

“It is penny wise and pound foolish to focus solely on the price of a new medicine while completely ignoring the value it provides to patients and the health care system broadly. 

“Curing Hepatitis C not only dramatically improves patients’ lives, but has the potential to save the U.S. health care system as much as $9 billion per year by preventing expensive hospitalizations and avoiding thousands of liver transplants that routinely cost over $500,000 each. 

“The health improvements and cost-savings new medicines provide explain why, despite repeated claims to the contrary, prescription drug spending continues to be a small and declining share of overall health care cost growth – a reality that often gets ignored in the public debate about drug costs. Continue reading

Susan Dolbert Named VP of Development for Rutgers Biomedical and Health Sciences

New Brunswick, NJ, May 22, 2014 — Rutgers University Foundation President Nevin Kessler and Brian Strom, Chancellor, Rutgers Biomedical and Health Sciences, today announced Susan C. Dolbert has agreed to assume the post of vice president of development, Rutgers Biomedical and Health Sciences (RBHS).  She will join the foundation on September 2.

Dolbert’s responsibilities will include building a strong development program for RBHS, which consists of eight schools, including two medical schools, a school of nursing, a school of public health, a school of pharmacy, a graduate school of biomedical sciences, a school of dental medicine and a school of health related professions.

In addition to the schools, RBHS also includes the Cancer Institute of New Jersey; the Center for Advanced Biotechnology and Medicine; the Environmental and Occupational Health Sciences Institute; the Institute for Health, Health Care Policy and Aging Research; and University Behavioral Health Care. Continue reading

Rutgers Cancer Institute Research: ‘Encouraging’ Period of Stable Disease Suggested in Direct Injection Vaccine Treatment of Pancreatic Cancer

New Brunswick, NJ, May 21, 2014 — Research from Rutgers Cancer Institute of New Jersey shows that the “first in man” series of vaccine injections given directly into a pancreatic cancer tumor is not only well tolerated, but also suggests an “encouraging” period of stable disease.

Results from a Phase I clinical trial conducted at the Cancer Institute of New Jersey are being given as part of a poster presentation at the American Association for Cancer Research (AACR) Pancreatic Cancer: Innovations in Research and Treatment conference being held in New Orleans this week.  Continue reading

Centenary College Launches New Master of Health Administration Program

Hackettstown, NJ, May 20, 2014 — The Centenary College last week announced an addition to the college’s portfolio of degree offerings:  a Master of Health Administration (MHA) degree, which will start this fall.

“This is such an exciting endeavor for Centenary College, as this is the first health-related degree we have ever offered,” says Dr. Barbara-Jayne Lewthwaite, President of Centenary College. 

“This is an innovative program that is uniquely designed address the changing health industry dynamics that are a result of the Affordable Care Act,” Dr. Lewthwait said.  “The health environment is fundamentally changing and this program will afford our students the development of leadership and management expertise in all vital areas of health administration.” Continue reading

12th NJ Symposium on Biomaterials Science Set for October 6 –7

New Brunswick, NJ, May 15, 2014 — The New Jersey Center for Biomaterials has announced that the 12th NJ Symposium for Biomaterials Science will be held in New Brunswick on October 6 and 7.

This year’s event will address the universe of biomaterials from synthetic polymers to processed natural tissues, and their development into new medical products.  This biennial event is regarded as the premier regional meeting on Biomaterials.

The following is a list of symposium speakers of May 5: Continue reading

HINJ Releases 2013 Economic Impact Report and ‘HINJ and NJ’s Life Sciences Community’ Brochure

New Brunswick, NJ, May 13, 2014 — The HealthCare Institute of New Jersey (HINJ) has released two new publications:  the 2013 Economic Impact Report and a new external (leave-behind) brochure entitled HINJ and New Jersey’s Life Sciences Community.

Printed copies of each publication are being mailed to HINJ member companies and to our many stakeholders, including members of New Jersey’s Congressional Delegation, Governor Christie and his administration and the State Legislature. Continue reading